Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based virtual screening protocols.

A Good1

  • 1Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA. Andrew.Good@bms.com

Current Opinion in Drug Discovery & Development
|September 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing pathology utilisation lies behind increasing pathology costs.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2013
Same author

Psychosocial determinants of socioeconomic inequalities in cancer screening participation: a conceptual framework.

Epidemiologic reviews·2011
Same author

Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England.

British journal of cancer·2009
Same author

Emergency thoracotomy: "how to do it".

Emergency medicine journal : EMJ·2004
Same author

Molecular basis of the anaerobic response in plants.

IUBMB life·2001
Same author

H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Structure-based virtual screening (SVS) is crucial for drug discovery. This review covers new SVS technologies, validation studies, and scoring methods, highlighting successes and limitations in identifying potential drug leads.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Pharmacology

Background:

  • Virtual screening is vital in pharmaceutical lead discovery.
  • Structure-based virtual screening (SVS) utilizes 3-D target active sites.
  • SVS is a key technology for identifying novel drug candidates.

Purpose of the Study:

  • To review recent advancements in SVS technology.
  • To highlight new methods for scoring ligand-protein interactions.
  • To discuss validation experiments and limitations of current SVS approaches.

Main Methods:

  • Review of recent literature on SVS.
  • Analysis of new technologies in ligand interaction sampling.
  • Examination of scoring functions for binding affinity prediction.

Related Experiment Videos

Main Results:

  • Successful applications of SVS in lead discovery were identified.
  • Current technological limitations in SVS were illustrated.
  • Novel scoring and ligand sampling methods show promise.

Conclusions:

  • SVS technology continues to evolve, improving drug discovery efficiency.
  • Further development in scoring and sampling is needed to overcome limitations.
  • SVS remains a powerful tool for identifying pharmaceutical leads.